Gilead Scales Up Remdesivir Production To Meet Indian Demand

Company Donates 450,000 Vials For Immediate Need

India COVID
Gilead encourages licensees to expand their local manufacturing capacity to meet Indian demand for remdesivir • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products